Renasight™

Renasight™ Genetic Kidney Panel
This program offers no-cost Renasight™ testing for eligible patients of African ancestry with chronic kidney disease. It supports early identification of APOL1 risk variants associated with APOL1-mediated kidney disease (AMKD). Providers can use results to inform diagnosis, guide management decisions, and determine whether genetic factors may underlie renal decline.